Skip to main contentSkip to navigationSkip to search

Code of conduct

Camurus current Code of conduct was adopted at a Board Meeting on 3 June 2021 and became operational from 5 July 2021.

1. Scope

The scope of this Code is to:

  • Apply globally to all Camurus products and services in order to respect human rights, promote fair employment, safe working conditions, environmental responsibility and ethical business standards.
  • Set out the business conduct and ethics for Camurus.
  • Assist the organization in their daily work and business activities to promote the long-term positive development of the Company.

2. Overview

Camurus strives to be recognized for the value it brings to patients, health care professionals (HCPs, society, customers and partners). We strive to always be trusted and respected for the way we conduct our businesses; research, develop and market our products.

Our professional activities and daily decisions should be supported by the objectives and reflect our respect for each other’s skills, viewpoints and decisions. We are energetic, proactive and innovative and always respectful of each other, our business partners, and customers.

This Code, including all matters contained herein, does not constitute any individual third party rights and may be subject to revisions from time to time. Camurus reserves the right to amend or replace this Code, including its content, without prior notice at any time.

3. Roles and responsibilities

RoleResponsibility and obligations
CEOEstablish, maintain and archive this Code
Line managersMake the Code known and promoting the Code
 Monitoring compliance
EmployeesConfirm that they have read and understood the Code
Promote core values by acting appropriately towards colleagues, business partners and society at large; and to take into consideration that when acting outside of the Company, Camurus’ Employees are regarded as representatives of the Company
Compliance with law and relevant regulation is a fundamental duty and an essential part of the responsibility of each Employee

4. Risk awareness

Corporate social and sustainable entrepreneurship are central to the whole world and also play an increasingly important role in corporate competitiveness, profitability and thereby also to sustainable shareholder value.

5. Policy

5.1. Research and development

Camurus is engaged in developing new and innovative medicines and medical products with the ultimate goal of contribute to lives of patients and a better society as a whole. Clinical research and the conduct of clinical trials in humans to evaluate the safety and efficacy of products for the diagnosis, treatment, and prevention of disease are critical components of medicinal product development. Camurus will always apply high ethical standards in the conduct of its research and development activities, complying with applicable laws and regulations, including the Declaration of Helsinki governing research and development performance (6), and international standards of good practices, such GLP (5)and GCP (4).

Camurus is fully committed to protecting the patients and volunteers who take part in our clinical trials; ensuring we uphold the highest ethical, scientific and clinical standards in all of our research initiatives; and providing study results in a timely, objective, accurate and complete manner and recognizes there are important public health benefits in making study results available to patients, health care providers, and the general public. All data from clinical research is recorded, handled and stored in a way that enables accurate reporting, interpretation and verification. Individuals participating in clinical trials should not be exposed to any unnecessary risks.

5.2. Products and services

Camurus is committed to providing only truthful, non-misleading and accurate information about the approved uses of our products and we never offer or promise anything of value to influence purchasing decisions. Patients and HCPs have a right to decide the best course of care, based on truthful, fair, substantiated and scientifically rigorous claims.

Camurus’ employees shall:

  1. Always give an accurate, non-misleading, balanced presentation of our products attributes, including relevant safety information.
  2. Only promote products for uses that have been approved in a manner consistent with the country-specific approved labeling.
  3. Never promise or provide anything of value to reward or encourage the use, purchase or recommendation of our products.
  4. Comply with applicable laws and regulations.

5.3. Product safety and quality

Patient safety is the highest priority for Camurus. In our research, development, manufacture, storage, distribution and post-marketing activities, we will comply with all applicable laws and regulations, including reporting of safety information designed to ensure the safety and quality of pharmaceutical products. We also will always adhere to our internal policies and standard operating procedures designed to protect patient safety and to ensure quality of our products.

Products on the market will continue to be monitored for adverse events, new and unexpected safety signals and the regulatory agencies will be informed about these in accordance with applicable rules and regulations. Every Employee is responsible for reporting any safety or performance issues relating to investigational drugs in clinical trials and our marketed products.

5.4. Interactions with healthcare professionals

Camurus is committed to, in all interactions with HCPs and organizations, apply the highest standards of integrity and honesty, and follow applicable laws and regulations and codes. There must be legitimate needs for engaging services of HCPs or organizations and any payment for services. Payments may furthermore only be provided if there is a written agreement governing the applicable services, and must not exceed reasonable market rate for such service.

5.5. Advertisement and promotion

Camurus is committed to complying with all applicable laws, regulations and industry codes governing promotional activities and advertising and will conduct these activities in an appropriate and ethical manner.

Applicable Company procedures are designed to ensure that our promotional information and advertisements follow applicable regulatory requirements and are accurate, balanced, and supported by scientific evidence, and are not false or misleading.

5.6. Interactions with government regulatory agencies

Camurus operates in a highly regulated industry. Governmental regulatory agencies routinely request information during audits, inquiries and investigations. All Employees shall deal honestly and professionally with such officials at all times.

5.7. Procurement

Camurus’ suppliers play an important role in our research, development and commercialization of the important medicines to the patients. We will always choose our suppliers based on objective criteria, and with the expectation that our suppliers will act in a manner consistent with our own commitment to lawful, fair and ethical business practices.

Camurus’ Employees shall always:

  1. Select vendors and suppliers based on objective criteria, such as price, merit, quality, service, reliability, and reputation.
  2. Make sure that vendors and suppliers comply with all legal requirements and local laws, and act in a manner consistent with our commitment to ethics and compliance as outlined in this Code.
  3. Report to the management all allegations of improper business practices, bribery and corruption relating to vendors and suppliers.
  4. Avoid conflicts of interest, inappropriate gifts and entertainment. Never accept any cash, credit, services, payments, loans, personal discounts or other favors from a vendor or supplier.

5.8. Anti-corruption and anti-bribery

Employee’s or third party’s acting on Camurus’ behalf should never make a payment or provide a benefit that is intended to improperly influence, or appears to influence, a business decision. This is particularly true in the case of public officials, government employees, HCPs and organizations, patients and patient groups. Violations of anti-bribery and anti-corruption laws, including local laws, are punishable by substantial fines and penalties, including imprisonment.

No Employee shall accept, offer or pay bribes or directly or indirectly accept gifts, hospitality, fringes or compensation in any form from a third party which may be unlawful or which could in any way affect his/her professional judgment in performing any duty or service for Camurus or a third party.

All payments made to a government official or private individual must be reported and appropriately recorded.

5.9. Competition and anti-trust laws

Camurus must comply with all applicable competition and anti-trust laws. These laws prohibit agreements with competitors, suppliers and customers to fix prices or to otherwise restrain trade. Antitrust and competition laws are vigorously enforced and can result in enormous financial penalties, as well as possible imprisonment for individuals, and must always be followed.

Camurus does not engage, directly or indirectly, in activities that may be viewed as anti-competitive or unethical, or in any activity involving bid-rigging or boycott. Employees of Camurus should not engage in discussions or activities that could lead to the appearance of improper behavior, and should never discuss issues relating to pricing, sales, inventory, or marketing plans with competitors.

5.10. International trade controls

In doing international business, Camurus is also committed to comply with laws, regulations, licensing requirements, boycotts, embargoes and other restrictions approved by recognized national and international authorities, including the United Nations, Sweden, European Union, and United States of America. Camurus will always provide accurate and correct information about our products to Customs authorities and other relevant authorities.

5.11. Political activities

Camurus supports the right to engage in personal political activities, as long as these activities remain private, are lawful and ethical, and are conducted on personal time with personal resources.

Camurus Employees shall never act, or appear to act, as a representative of Camurus when engaging in personal political activities; or use Camurus’ assets, including work time, equipment or facilities, for personal political purposes, or solicit contributions or distribute political materials during work hours

5.12. Data privacy

Camurus may in the conduct of its business collect and use personal information. Camurus is committed protecting individuals from unauthorized use and disclosure of their personal information, and providing individuals with transparency and choices regarding how their personal information is used.

Camurus will always comply with Data Privacy laws and related regulations regarding collection, use, retention and disclosure of personal data gathered or entrusted to Camurus. Employees shall always respect the sensitivity regarding collected or entrusted personal data, and make sure such data is secure so that the integrity of such data is not risked and that such data are not wrongfully disclosed.

5.13. Conflict of interest

A conflict of interest can occur when an Employee’s private interest interferes with the interests of the Camurus. We should always avoid that any private interests influences our ability to act in the interests of Camurus, or makes it difficult to perform our work objectively and effectively.

All Camurus’ Employees must disclose any situations that reasonably would be expected to give rise to a conflict of interest.

5.14. Company records, disclosures and securities transactions

Company records shall always comply with all applicable laws and regulations and company policies relevant to corporate accounting. We will record all transactions on the company books accurately and properly in accordance with generally accepted accounting principles. We will always maintain internal control systems to ensure that all transactions are accurately and properly recorded, and never make any false or artificial entries.

Disclosures of company information shall always be made timely and accurately disclosure of company information to investors. We will comply with all applicable laws and regulations and company policies regarding financial disclosures. All Employees involved in public disclosures will familiarize themselves with these laws and regulations and company policies. All communications and disclosures on behalf of Camurus must be fair, true, correct, timely and not misleading and may be made only by authorized individuals. Any uncertainty about the validity of any entry, data, record or report must be immediately reported to a manager or supervisor.

Insider trading is strictly prohibited and we will comply with all securities laws and regulations restricting insider trading of securities. If we become aware of “material non-public information” concerning Camurus, or any company transacting business with Camurus, we will not buy or sell securities of Camurus or the other company, either on our own account or on behalf of Camurus or any others. Moreover, we will never provide material non-public information to others, until it is publicly disclosed in accordance with applicable laws, regulations and company procedures. “Material non-public information” is any non-public information that could have a material influence on investors’ decisions to sell or buy securities. Examples may include issuance of shares, repurchase of shares, mergers and acquisitions, commercialization of new products, progress or failure of clinical trials, and material changes in financial forecasts.

Information is “non-public” if it has not been made generally available to the public by means of a press release or other means of widespread distribution. Information is “material” if a reasonable investor would consider it important in a decision to buy, hold or sell shares or other securities.

The Camurus Insider Policy and Guidelines (1) and the Camurus Communication Policy (2) further specifies applicable standards and obligations in respect of disclosures and insider trading.

5.15. Company property and intellectual property

Camurus physical assets, such as equipment, materials, supplies, money, and its intangible assets, like intellectual property, confidential information, value of our products and brand names, business relationships and Employees’ time, skills and talent, may be used solely for the benefit of Camurus and its business, and not for personal or any inappropriate purpose.

Employees of Camurus shall not engage in business activities outside Camurus which would negatively impact the attention and time required to fulfil their responsibilities at Camurus or may require that such activities have to be performed during regular working hours at Camurus.

Camurus’ Employees shall protect the Camurus’ properties and ensure their efficient use for its different business purposes. The use of Camurus’ funds or assets for personal gains and other improper purposes is strictly prohibited. Camurus’ equipment is intended for business purposes and not for personal use, other than incidental use that is reasonable and permitted by Camurus’ policies.

Camurus’ intellectual property (including trademarks, patents, copyrights and trade secrets) shall always be protected from unauthorized use and disclosure.

5.16. Media and communications

Shareholders, investors, partners, customers and the public rely on Camurus’ to provide accurate and reliable information about our operations, performance and future outlook. As information can be spread widely and instantaneously via the Internet and other media, it is important that our communications with external audiences are consistent and aligned with the policies and needs of the Company. For this purpose, it is critical that communication is coordinated and only goes via defined functions:

  1. Press and media inquiries should be referred to the CEO. Camurus’ business should never be discussed on or off the record.
  2. Investor inquiries should be directed to the CEO or the Head of IR. All meetings with investment professionals should be done after information to, and approval by the CEO.
  3. Speaking engagements always require approval from management, following appropriate internal review and approval processes.
  4. Submission of abstracts and articles for publication always require written approval and following appropriate internal review and approval processes.

The Camurus Communication Policy (2) further specifies applicable standards and obligations in relation to media and communication.

5.17. Confidential information

Employees have access to a variety of confidential information while employed at Camurus. Confidential information includes all information that is internally generated by Camurus concerning the business of Camurus. It may also include information obtained from sources outside Camurus, including information about other companies or their securities. Confidential information includes all non-public information that might be of use to competitors, or, if disclosed, harmful to Camurus or its customers. Employees have a duty to safeguard all confidential information of Camurus or third parties with which Camurus conducts business, except when disclosure is authorized or legally mandated. An Employee’s obligation to protect confidential information continues after he or she leaves Camurus. Unauthorized disclosure of confidential information could cause competitive harm to Camurus or its customers and could result in legal liability to the Employee and Camurus.

5.18. Workplace

Camurus is committed to being a positive workplace, free from discrimination or harassment of any kind. We value the contributions of each individual and group and treat one another with respect, regardless of position, statue or relationship. Camurus does not tolerate any form of harassment and bases all employment-related decisions, such as recruitment, hiring, remuneration, promotion and development opportunities on the job qualifications, merit and/or performance of the individual, without regard to gender, sexual orientation, age, race, or identity expression, or other characteristics protected by applicable laws. Employees should never harass, degrade or discriminate against others and never behave in a violent or threatening manner.

Camurus is also committed to complying with all applicable employment laws and regulations as well as the principles laid out in the United Nation’s Universal Declaration of Human Rights (3). Camurus is also respectful of its Employees’ right to join and form independent trade unions and freedom of association.

5.19. Safety, health and environment

Camurus always strives to provide a safe and secure work environment where no one is subject to unnecessary risk. Safety and health considerations should be integrated into everything we do. Camurus has adopted policies and procedures to facilitate workplace safety. Employees are expected to identify and understand the risks associated with their work, manage risks responsibly, and only perform work for which adequate training has been provided.

Employees should promptly report all environmental, health and safety issues, including unsafe conditions, accidents, near misses and work-related injuries; and promptly report all security issues, including threatening or violent behavior to their manager.

Camurus is further committed to conducting business in an environmentally responsible way, enhance and reduce the environmental impact of our work and our products and support waste reduction and energy-saving initiatives.

In addition to minimizing the risks for exposure to chemical, biological and other hazards and proactively reduce the risk for accidents in the work place, Camurus supports programs aimed at improving the health and wellbeing of the Employees.

5.20. Violations

Violation of this Code is not accepted and may result in formal sanctions being applied, according to the nature and severity, and according to all applicable laws and regulations.

6. Policy compliance

The Code applies to all Employees at Camurus.

7. Abbreviations and definitions

AbbreviationDefinition
CamurusCamurus AB (publ), Reg. No 556667-9105
CEOChief Executive Officer
CompanyCamurus AB (publ), Reg. No 556667-9105
Declaration from Helsinki governing research and development performanceWMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects
EmployeeDirectors, officers, employees, permanent and temporary, contrators, agents and agents working on behalf of Camurus
GCPGood Clinical Practices
GLPGood Laboratory Practices
HCPHealth Care Professionals
Head of IRHead of Investor Relations
The CodeCode of Conduct

 8. References

  1. Camurus’ Insider Policy and Guidelines
  2. Camurus’ Communication Policy
  3. United Nation’s Universal Declaration of Human Rights
  4. GCP
  5. GLP
  6. Declaration of Helsinki governing research and development performance

9. Revision summary

Version #Cause of Revision/History LogValid from Date
  

10. Approval of policy

Approved by:Date / Signature:
Adopted at Board Meeting3 June 2021

This Code, including all matters contained herein, does not constitute any individual third party rights and may be subject to revisions from time to time. Camurus reserves the right to amend or replace this Code, including its content, without prior notice, at any time.